Flare Therapeutics Secures $85M Series C Round
· vcnewsdaily.com
CAMBRIDGE, MA, Flare Therapeutics, a clinical-stage biotechnology company, announced the closing of an $85 million Series C financing.
Flare Therapeutics Secures $85M Series C Round Back to Home
CAMBRIDGE, MA, Flare Therapeutics, a clinical-stage biotechnology company, announced the closing of...